Nerrropharmarology, 1971,10,459-469 Pergamo~l Press. Printed
in Gt.Britain.
EVALUATION OF A RAPID TECHNIQUE FOR DETECTING MINOR TRANQUILIZERS C. ARON,P. SIMON,C. LAROUSSE and J. R. BOISSIER Unite de Recherches de Neuropsychopharmacologie 2, rue d’Alesia, Paris 14tme
de I’INSERM,
(Accepted 21 November 1970)
Summary-A technique, based on the inhibition by foot-shocks of a simple ongoing behaviour in mice (ambulation), is suggested for the preliminary screening of the minor tranquilizers. The effect of a large number of psychotropic drugs was studied: they include minor tranquilizers, hypnotics, anticonvulsants, antihistamines, neuroleptics, antidepressants, antiparkinsonism agents, stimulants, analgesics and others. The efficiency, specificity, reliability, simplicity and disadvantages of the method are discussed.
“MINOR TRANQUILIZERS", as distinguished from the “major tranquilizers” or “neuroleptics”, have been used in man to treat symptoms of anxiety and tension and of some psychoneurotic and psychosomatic disorders. They have also been used as an adjunct of neuroleptic medication, but have not been found to affect psychotic symptoms. At the present time, no satisfactory experimental method or design is available to produce, in animals, manifestations of anxiety similar to those observed in man. The techniques now existing have already been described in several reviews (COOK and KELLEHER, 1963; IRWIN, 1968; RANDALL and SCHALLEK, 1968; BOISSIERand SIMON,1969; GIURGEA,1969). Two main types of procedure have been used in attempts to detect the suspected “tranquilizing activity” of a new compound. The techniques belonging to the first type can easily be used for a fast preliminary screening: the association of sedative activity with anticonvulsant, anti-aggressive and muscle relaxant action is looked for; however, the relation between all these properties and the therapeutic effect is far from clear. The techniques belonging to the second type may possibly have more to do with the therapeutic effect. They are based on conditioned “emotional” reactive patterns, but the length of time involved in their application limits their use for the preliminary screening of new potentially anxiolytic agents. In a previous study (BOISSIER et al., 1968) the present authors suggested the use, in mice, of a rapid screening method involving the inhibition of a simple exploratory behaviour of a new environment by the application of an electric shock to the paws of the animal. Indeed, the minor tranquilizers studied were found to diminish this induced inhibition. The aim of the present study was to discover if this method could differentiate drugs with minor tranquilizing activity from all other psychotropic drugs. Because the druginduced disinhibition could result from a stimulating effect rather than from a decreased “anxiety”, we also investigated whether or not the behavioural disinhibition observed could be secondary to an increase in motor activity. 4.59 THE
460
C. ARON,P.SIMON, C. LAROUSSE and J. R. BOISSIER METHODS
The four-plates test Apparatus. The box was first used by SLOTNIK and JARVIK (1966) in their study of
septal mice. The chamber is made of an opaque plastic and has the shape of a parallelepiped rectangle (25 x 18 x 16 cm). The floor is covered with 4 rectangular metal plates (Il.3 x 7.7 cm) separated from one another by a gap of 4 mm. The plates are connected to a source of direct current and a 180 V difference of potential between 2 adjacent plates occurs for 0.5 set when the experimenter presses a switch. The voltage and duration parameters were selected in order to evoke a clear flight reaction in the control animals. Testing procedure. At the beginning of a test, a mouse was gently dropped onto a plate and allowed to explore the enclosure for 15 sec. Every time the mouse crossed from one plate to another, the experimenter pressed the switch and electrified the whole floor for 0.5 set; the mouse often crossed 2 or 3 plates; if it continued running, it received no new shock during the following 3 set; the number of times the apparatus was electrified was counted during the minute after the 15 set exploration. A parametric study was made to choose the values of the different variables (ARON, 1970). The activity box
The apparatus
based on photocells BOISSIERand SIMON (1965) was used.
(DEWS,
1953),
which has been described by
Animals
Male mice of a Swiss strain (Charles Rivers), weighing from 18 to 25g, were used. Drug administration
All drugs were injected intraperitoneally 30 min before testing, except for reserpine, iproniazid and pargyline which were injected 24 hr before testing. Drugs were given in a water solution or in suspension with arabic gum, so that all mice received 0.5 ml of liquid for 20g of body weight. For each drug dose tested by the four-plates method, a group of 12 mice was compared to a group of 12 control animals injected with water or an arabic gum suspension. For the measures of activity, groups of 6 mice were used. The following drugs were tested: alimemazine, amitriptyline, hydrochloride, amobarbitone, dexamphetamine sulphate, aspirin, atropine sulphate, beclamide, benactyzine hydrochloride, butesamide, butobarbitone, caffeine, captodiamine, hydrochloride, chloral hydrate, chlorpromazine hydrochloride, clofenamide hydrochlordiazepoxide hydrochloride, bitartrate, dextropropoxyphene cresoxydiol, dextromoramide chloride, clorazepate, hydrochloride, diazepam, dibenzepine hydrochloride, diethazine hydrochloride, diphencloxazine hydrochloride, diphenhydramine, dispranol, emylcamate, eserine sahcylate, ethosuximide, N ethyl 3 piperidyl phenyl cyclopentyl (Ditran@), Auoresone, fluphenazine dichlorhydrate, haloperidol, hydroxyphenamate, hydroxyzine dichlorhydrate, imipramine hydrochloride, iproniazid, levomepromazine hydrochloride, lysergamide, mecloqualone, mephenoxalone, mephenytone, meprobamate, mesoridazine napadisylate, methaqualone, methocarbamol, a-methyldopa, methylpentynol carbamate, a-methyiparatyrosine hydrochloride, methysergide, metoclopramide, molindone, morphine hydrochloride, oxazepam, oxomemazine, DL parachloromethylamphetamine hydrobromide, parachlorophenylalanine, pargyhne, pemoline, pethidine hydrochloride, phenaglycodol, phenobarbitone, phensuximide, phenyl-acetylurea, phenytone, pimetixene, pimoside, prenylamine lactate, primidone,
Evaluation of a rapid technique for detectingminor tranquilizers
461
procyclidine hydrochloride, promethazine, propranolol hydrochloride, reserpine, scopolamine hydrobromide, sulpiride, tetrazepam, thalidomide, thioridazine hydrochloride, trihexyphenidyle hydrochloride, trimethadione, trimetosine, valnoctamide, yohimbine hydrochloride. RESULTS Control animals The first shock induced a flight reaction; the animal squeaked, ran across 1 or 2 plates and then froze in a corner of the box. It trembled, exhibited piloerection and urinated. After a few seconds, it slowly resumed its exploration, tentatively explored the adjacent plate edges with its paw or its nose, eventually placing its 2 fore-paws on one of the plates. At that moment, the plate was again electrified. An early or a late electrification, as related to the passage of the gap, totally changed the behaviour of the animals. If the floor was electrified exactly when the animal had 2 paws on one plate and 2 on the other, it induced the typical flight reaction. If it was electrified earlier, for example when the mouse had only 1 paw on the next plate, the animal retreated very fast and showed considerably fewer autonomic reactions (piloerection, urination, etc.). If it was electrified later, for example when only 1 paw was left on the first plate, the same happened: very rapid escape from the shock, very few autonomic reactions, Correct timing, therefore, seemed important. Within the first minute, the animal would normally take from 1 to 10 shocks, as shown in Fig. 1. The distribution of the results was close enough to the normal distribution for us to be able to compare the group of control mice to the group of treated ones by means of the t-test. We were interested only in evaluating the significance of the difference
__AI
2
Number FIG.
i
3
4
of shocks(N)
received
1. Distributionof resultsfor 600control animals.
462
C. ARON, P. SIMON,C. LAROUSSE and J. R. BOISSIER
between the increase in the number of punished crossings from one plate to another of treated mice and that of the controls. The activity measures were used only as a qualitative index of stimulation or sedation in a different environment. Pre-treated mice
For the treated mice, the number of punished crossings was increased by 2 groups of drugs. In the first group were various types of psychotropic drugs which all increased motor activity: caffeine, cocaine, dexamphetamine, DL parachloromethylamphetamine, phenobarbitone, trihexyphenidyle (Table 1). In the other group were substances which did not increase motor activity: firstly, drugs which clinicians know as minor tranquilizers : benactyzine, chlordiazepoxide, diazepam, emylcamate, hydroxyphenamate, meprobamate, oxazepam, phenaglycodol and trimetosine (Table 2) ; and secondly, 2 hypnotics (butobarbitone and chloral hydrate), 2 anticonvulsants (mephenytone and phenacetylurea), 2 antihistamines (diphenhydramine and promethazine), 1 antidepressant (amitriptyline), 1 central anticholinergic (Ditran@) (Table 3). Among the drugs which did not increase the number of punished crossings were some drugs reputed as minor tranquilizers (Table 4), most of the anticonvulsants, antihistamines, drugs used in parkinsonism, and antidepressants, and all the neuroleptics and the central analgesics which we have studied. Also among them were: lysergamide and methysergide, antiserotonin agents, and parachlorophenylalanine, an inhibitor of serotonin synthesis; a-methyl-dopa, metoclopramide and sulpiride which have some relation to the neuroleptics, prenylamine, a sedative drug, propranolol, a /3-adrenergic-blocking agent, yohimbine an a-adrenergic-blocking agent, a-methylparatyrosine, an inhibitor of tyrosine hydroxylase and finally eserine (Table 3). DISCUSSION
The first point of significance is the route of administration of the drugs and the interval chosen between the injection and the testing. We decided to keep these 2 parameters constant so as to maintain our usual conditions for preliminary screening. Probably, this fact alone accounts for some of the negative results and for differences within a given class of drugs. Another handicap may have been the similarity of the punished behaviour to the locomotor reaction induced by the punishment itself: punished behaviour was the crossing of a gap, at a normal or a slow pace, and the locomotor reaction induced by the punishment was a flight during which the mouse ran, squeaked and would, as a rule, cross l-3 gaps, unpunished. What are the factors or drug actions which might affect the behaviour of mice in the test situation? If their behaviour were primarily controlled by 2 main sets of motivation -on the one hand, the desire to move or to explore the new environment and on the other, the fear of moving, of crossing the gaps, caused by the foot-shocks-it is evident that certain drug actions should affect the results of the test. It is to be expected that the number of shocks received in any 1 min would increase if the overall drive to move were increased, if the sensitivity to the shock were decreased, or if the short-term memory of the animal were modified. It could not be inferred with certainty from this test that a drug known to have any of these actions had a tranquilizing action. For example, phenobarbitone has been used by clinicians at low doses as a minor tranquilizer. It does increase the number of punished crossings in the test, but it does so at a dose which increases spontaneous activity as well. Therefore, in a preliminary screening, we might have attributed
463
Evaluation of a rapid technique for detecting minor tranquilizers TABLE
1. DRUGS WHICH INCREASED BOTH PUNISHED BEHAVIOLJRIN THE TEST AND AMBULATION [Number of punished crossings, expressed as a percentage of controls (10 mice per group)]
-
Doses (mg/kg i.p.) 30 min before the test 0.5
1
2
4
8
16
32
120
118 (144) 131
141* (216) 150* (119) 109
175* (310) 264% (174) 147 (120)
214* (445)
272* (516)
Pemoline
130 (161) 146* (90) 111
(1::)
(Z)
Cocaine
81 (1::)
(KZ;
(37899
&
Caffeine
121
117 (131)
133 (273)
153 (267)
178* (154)
187* (157)
153* (246) 185* (178)
200* (152)
146* (135)
0.12
0.25
o-Amphetamine Parachloromethylamphetamine
118
Trihexyphenidyl
117 (112)
167* (124)
177* (135)
_-__ *The difference from the controls is statistically significant (P < 0.05). Figures in parentheses refer to motor activity, expressed as a percentage of controls.
TABLE 2. MINOR TRANQUILIZERS WHICH INCREASED THE PUNISHED BEHAVIOUR
[Number of punished crossings. exuressed as a percentage of controls (10 mice per group)] Doses (mg/kg i.p.) 30 min before the test 0.5 Chlordiazepoxide
1 104
2
Oxazepam
97
124 (81) 198% (90) 116
Benactyzine
99
188*
Diazepam (1::)
,:ZY;
4
8
16
32
115 (56) 205* (49) 195* (91) 210* (97)
146* (26) 50
160* (13)
100
162* (58) 261* (104)
150* (37) 199* (102)
Emylcamate
137 (59)
Hydroxyphenamate Meprobamate
100
Phenaglycodol
143
Trimetosine
89
113
130 (62)
150* (58)
64
128
256
201* (101) 134 (91) 148* (128) 163
215* (76) 194* (106)
183
140
63 (47)
(%; 178* (65) 83
133 (10) 70
*The difference from the controls is statistically significant (P < 0.05). Figures in parentheses refer to motor activity, expressed as percentage of controls.
C. ARON, P. SIMON,C. LAROUSSEand 5. R. BOIWER
464
TABLE3. EFFECTOF VARIOUSPSYCHOTROPIC DRUGS:PART I [Number of punished crossings, expressed as a percentage of the controls (10 mice per group)] Doses (mg/kg i.p.) 30 min before the test 0.125
0.25
0.5
1
2
Hypnotics Phenobarbitone Butobarbitone
4
8
16
32
64
100
106
108
96
220*
242*
160’ (139) 251*
(146)
(67) 100 59 95 129
(86)
‘;;I
68 95 123
87 104 125
147 129
147 114
147 142
95
Amobarbitone Mecloqualone Methaqualone Chloral
100 67
77 99
Anticonvulsants Phenytone Mephenytoine
126
Primidone Trimethadione Phensuximide Ethosuximide Beclamide Phenylacetylurea
127 106 83
Antihistamines Alimemazine Diphenhydramine
75
Oxomemazine Pimetixene Promethazine
Neuroleptics Chlorpromazine Fluphenazine Levopromazine Thioridazine Mesoridazine Haloperidol t Pimozide Reserpine Reserpine (during 5 days) Sulpiride Molindone
100
100 94
82
96
75
130 90
94 78 88
50 95 125
90 56 87
100
84 108
(101) 103
(120) 121
73
125
80 157* (81)
100 (66)
91 84 141 (30)
74 55
39
61
75
46 74 82
67 67
125 102
90 33
72
77
76
73
63
(Z)
*The difference from controls is statistically significant (P < 0.05). t Haloperidol was shown inactive down to 0.03 mg/kg. Figures in parentheses refer to motor activity, expressed as a percentage of controls,
147 186* (102) 108 99
127
108 155*
84
104 169* (88)
89
96 166*
256
127 (61)
90 62 121 100
106
128
92
240* (96)
167 152* (105) 102
110 96 85 123 157* (129)
80 97 36 175* 243* (86)
Evaluation
of a rapid technique for detecting minor tranquilizers
465
TABLE 3. EFFECT OF VARIOUS PSYCHOTROPIC DRUGS:PART II [Number of punished crossings, expressed as a percentage of the controls (10 mice per group)1
Doses (mg/kg i.p.) 30 min before the test 0.125
0.25
0.5
1
Antidepressants Pargyline Iproniazid Dibenzepine Imipramine Clomipramine Amitriptyline
Anti-parkinsonism Atropine Scopolamine Diethazine Procyclidine
4
8
16
105 83
9.5
100
113
125
122 140
80
100 103
89
126 94
55 98 113 147* (87)
65 98 112 159* (76)
107
87
86
58
85 125
110 134
118 132 118
63
31
123 131
63 105
83
55
132
151 102
81 132
110
105
50 96
89
149”
32
64
128
256
119
105 88 70
117 105
110 97
101
72
133
114
93
97
85 109 110
114 135
110 119
Analgesics Aspirin Dextromoramide Dextropropoxyphene Morphine Pethidine
Various other drugs Lysergamide Ditran” Methysergide Yohimbine Eserine a-Methyldopa Prenylamine Metoclopramide Propranolol Parachlorophenylalanine (per 0s) a-Methylp-tyrosine
2
60
172* 67 64
92 56 130
86 51 130
128 102
114
134 104 95
466
C. ARON, P. SIMON,C. LAROUSSEand J. R. BOISSIER TABLE4. MINOR TRANQUILIZERS WHICH DID NOTSIGNIFICANTLY INCREASE THE PUNISHED BEHAVIOUR [Number of punished crossings, expressed as a percentage of controls (10 mice per group)] Doses (mg/kg i.p.) 30 min before the test 0.5
Butesamide Captodiamine Clofenamide Clorazepate Cresoxydiol Diphencloxazine Dispranol Fluoresone Hydroxyzine Mephenoxalone Methocarbamol Methylpentynol Tetrazepam Thalidomide Valnoctamide
87
1
2
4
8
12
123
80
79
82
75 89
92 120
60 62
48 14
62
68
52 78
1;: 98
92
112
81 120
97 104
16
256
32
64
128
58 45
61 45
59
85
81
60
78 135 79
82 130
109 85
75
86 141 104 126 61
95 90 85
140 93
150 93
75 69 140 68
103
80 78 102
512
85 81
109 -
--
its effect on the test to overall stimulation. This raises a problem of interpretation: if a minor tranquilizer is found to have slightly stimulating effects, the result may be taken for those given by a stimulant and the minor tranquilizing property overlooked. This ambiguity is likely to be classified by more elaborate tests (based on Conditioned Emotional Response or conflict). We would discard without hesitation, in view of the results of motility measures which reflect their well known stimulating action, caffeine, cocaine, dexamphetamine, DL parachloromethylamphetamine, phenobarbitone and trihexyphenidyl. For all the other drugs which were shown to affect the test positively, since they are neither known as analgesics nor as affecting memory in man, we would tend to postulate that they do, in fact, possess an anxiolytic activity. It appears, however, that not all drugs known as minor tranquilizers and not all hypnotics, do increase the number of punished crossings. Perhaps, therefore, they do not really have an anxiolytic action. It is possible that the test does not detect those drugs which are anxiolytic at sedative doses. This is made all the more likely by the fact that these drugs were selected by pharmacologists from a large number of substances producing sedation. Whether a tranquilizer should be a sedative is a matter for discussion; a therapeutic dose of a minor tranquilizer is not necessarily a sedative one. It has been shown in rats that prolonged treatment will attenuate oxazepam-induced sedation but not its “disinhibitory or therapeutic effect” (MARGULES and STEIN, 1968). That mephenytone and phenacetylurea have minor tranquilizing properties is possible but is of no consequence since these drugs are too toxic to be used as minor tranquilizers. Two antihistamines out of 5 increased punished crossings, thus indicating anxiolytic action. This seems to confirm a recent study by RAULT (1969) who could not find a central property common to all antihistaminic drugs. Amitriptyline has been singled out by the test among all the antidepressants studied. Some clinicians view it as the antidepressant that can be given to depressed patients with a lesser risk of suicide. The result of this study suggests that part of its therapeutic efficacy might be related to its anxiolytic action.
Evaluation of a rapid technique for detecting minor tranquilizers
461
No neuroleptic, at any dose, gave positive results. However, at low doses, some neuroleptics-for example fluphenazine (RICKELSet al., 1968)-are sometimes used instead of benzodiazepines and shown to have the same action on some types of patients. This test, like all so far known except that of VOGELet al. (1969), has the disadvantage of not discriminating between those neuroleptics which possess an anxiolytic property and those which do not. Morphine, in contrast to what could be expected of an “analgesic”, did not increase the number of punished crossings and even decreased it. Similar results have been found before (BARRY and MILLER, 1962) in conflict situations involving foot-shock punishment. There is no simple satisfactory explanation. Yohimbine significantly decreased the number of punished crossings. It has been reported to induce anxiety (LANG and GERSHON, 1963) and thus it is not surprising that it acts in a manner opposite to that of the minor tranquilizers. On the whole, what is the value of the test? Does it have any of the virtues which JANSSEN(1964) asks the ideal screening test? “High eficiency, high speed, simplicity”? This technique is simple, does not require expensive equipment nor unusual animals. Three doses of a drug can be studied within 1 hr, even by an untrained experimenter. It might be asked why the test is not automatized; the reason is that we have not found the perfect system that would shock the animal exactly when-and only when-it is actually crossing a gap. “Reproducibility” ? The behaviour of the control animals is very reliable and for the standard-drugs like diazepam, chlorpromazine, imipramine, we have been able to repeatedly reproduce the results. “SpeciJicity, a given drug effect being characteristic of a well-defined class of chemicals and indicative of a spec@c mode of action”? The question arises here of how precisely
the group of the minor tranquilizers is defined. In the introduction, we defined them by their clinical activity but this raises the problem of the methodology and interpretation of clinical studies. What is studied is difficult to quantify, and criteria of anxiety, emotion or neurotic symptoms have often been arbitrarily chosen. Besides, even though many studies have been made in this field, they often lack a control group of subjects and this makes them almost meaningless. Therefore, we did not think it possible to take into account a great number of the drugs classified as minor tranquilizers to prove (or disprove) that the test does indeed screen out all the minor tranquilizers known at the present time. The well known benzodiazepines, diazepam and chlordiazepoxide, are generally recognized by most clinicians to possess therapeutic activity and they have always given positive results in this test. Clearly the minor tranquilizers were not the only drugs which gave positive results in the test. Stimulating drugs also increased punished responses, but the 2 groups could easily be differentiated by simple observation, or by measuring motor activity. There is not enough evidence to prove that there is only one specific mode of action for all the non-stimulating drugs which gave positive results in the test. “Adequate design, adequate data processing,
statistical analysis and symbolization” ?
Randomization can easily be-and must be-complete, and the experimenter should work in a blind manner. We found that, under those conditions, the subjective bias could almost be eliminated, since a change of experimenter did not bring about different results. The statistical analysis of the results presents no difficulty. “Good correlation with other tests . . . in man”? We can only speculate on this, even if
468
C. ARON, P. SIMON,C. LAROUSSEand J. R. BOISSIER
we change the requirement to “relationship of what is observed in the test situation to those clinical effects which are looked for”. It could be asked whether the effect of the minor tranquilizers on the punished crossings does not, in fact, reflect a side effect of these drugs which has nothing to do either with anxiety or with any of the symptoms against which the drugs are used. It would be difficult to say that we have here a model of a conflictual situation, in which the control animals react in an ill-adapted way, but in which the animals treated with minor tranquilizers react in a much more adapted manner; there is no evidence of this. But it can be said that in this test situation, the animals are motivated by 2 antagonistic drives, as suggested earlier. Under the influence of the minor tranquilizers, for example diazepam, what happens seems like an underestimation of the negative reinforcement (or “risk”) or an overestimation of the positive reinforcement (or “reward”): such an effect might be therapeutic if underestimation of rewards and overestimation of risks is an important factor in human neuroses. In the everyday life of a well-adapted person, however, such an effect would clearly be undesirable at times. One would, for example, assume from this that a driver under the influence of a minor tranquilizer could be a dangerous driver. To conclude: what place does this test have among those already in use ? Since existing tests are unspecific or long, and since this test is simple, reproducible, fast and reasonably efficient and specific, it would appear to be useful in a preliminary screening as one of a battery of tests. A drug active in this test should be studied further, with the longer and probably more specific tests based on conditioned emotional responses or conflict. Prolonged systematic use of this test by several experimenters should indicate its value. REFERENCES ARON, C. (1970). Dun test pharmacologique utilisable pour la selection de tranquillisants. These de Medecine, Paris. BARRY, H. and MILLER, N. E. (1962). Effects of drugs on approach-avoidance conflict tested repeatedly by means of a “telescope alley”. J. camp. physiol. Psychol. 55: 201-210. B~ISSIER,J. R. and SIMON,P. (1965). Action de la cafeine sur la motilite spontanQ de la souris. Archs int. Pharmacodyn. Thk. 158: 212-221. BOISSDER, J. R. and SIMON,P. (1969). Evaluation of experimental technique in the psychopharmacology of emotion. Ann. N. Y. Acad. Sci. 159: 898-914. BOISSIER,J. R., SIMON,P. and ARON, C. (1968). A new method for the rapid screening of minor tranquilizers in mice. Eur. J. Pharmac. 4: 145-151. &oK, L. and KELLEHER,R. T. (1963). Effects of drugs on behavior. A. Rev. Pharmac. 3: 205-222. DEWS, P. B. (1953). The measurement of the influence of drugs on voluntary activity in mice. Br. J. Pharmac. Chemother. 8: 4U8. GIURGEA,C. (1969). Pharmacological criteria for the classification of tranquilizers. In: The Present Status of Psychotropic Drugs (CERLETTI,A., Ed.), pp. 154-167. Ext. Med. Foun., Basle. IRWIN, S. (1968). Anti-neurotics: Practical pharmacology of the sedative-hypnotics and minor tranquilizers. In: Psychopharmacology, u Review of Progress, 1957-1967 (EFRON, D. H., Ed.), pp. 185-204. Public Health Service Publications, Washington. JANSSEN,P. A. J. (1964). Screening tests and prediction from animal to man. In: Animal Behavior and Drug Action (STEINBERG,H., Ed.), pp. 264-268. Churchill, London. LANG, W. J. and GERSHON,S. (1963). Effects of psychoactive drugs on yohimbine-induced responses in conscious dogs-a proposed screening procedure for anti-anxiety agents. Archs int. Pharmacodyn. ThPr. 142: 457-472. MARGULES,D. L. and STEIN,L. (1968). Increase of antianxiety activity and tolerance of behavioral depression during chronic administration of oxazepam. Psychopharmacologic 13: 74-80. RANDALL,L. 0. and SCHALLEK,W. (1968). Pharmacologic activity of certain benzodiazepines. In: Pyschopharmacology, a Review ofProgress, 1957-1967 (EFRON,D. H., Ed.), pp. 153-184. Public Health Service Publications, Washington.
Evaluation of a rapid technique for detecting minor tranquilizers
469
RAULT, B. (1969). Contribution a I’btude de l’action psycholeptique experimentale des anti-histaminiques. Thtse de pharmacie, Paris. RICKELS, K., RAAB, E., GORDON, P. E., LAQUER,K. G., DE SILVERIO,R. V. and HESBACHER,P. (1968). Differential effects of chlordiazepoxide and fluphenazine in two anxious patient populations. Psychopharmacologiu 12: 181-192. SLQTNIK,B. M. and JARVIK, M. E. (1966). Deficits in passive avoidance and fear conditioning in mice with septal lesions. Science, N. Y. 154: 1207-1208. VOGEL,J. R., BEER,B. and CU)DY, D. E. (1969). A simple and reliable conflict procedure for the evaluation of minor tranquilizers. Phurmacologist 11: 246.